Medicilon
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Medicilon Expands Global Presence with Official Opening of Second R&D Center in Massachusetts 2024-08-29 20:30
Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs 2024-07-31 22:39
Medicilon has appointed Dr. Qingcong Lin as President of Medicilon USA Corp., further deepening the global strategic layout 2024-03-11 20:30
Medicilon appoints Dr. Zhang Haizhou as President of Preclinical R&D Unit 2024-01-09 21:30
Dr. Liu Jian, President of Medicilon Drug Discovery Division, wins the Thomas Alva Edison Patent Award 2023-11-28 21:30
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together 2023-07-31 20:30
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division 2023-07-12 18:46
1